Literature DB >> 12081199

Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer.

Iris D Nagtegaal1, Corrie A M Marijnen, Elma Klein Kranenbarg, Adri Mulder-Stapel, Jo Hermans, Cornelis J H van de Velde, J Han J M van Krieken.   

Abstract

Short-term preoperative radiotherapy in combination with surgery has been shown to decrease the rate of local recurrence in rectal cancer patients. The effects of this type of radiotherapy on the histopathology of rectal carcinoma has been hitherto unknown. Since various histopathological factors are associated with prognosis, the study of alterations induced by irradiation is an important issue. This paper examines the histopathology of resection specimens from 1306 patients who were treated in a randomized trial that evaluated the benefits of preoperative radiotherapy. In this trial, patients were treated with short-term radiotherapy (5 x 5 Gy) and operated on within 5 days after radiation. Histopathological parameters were determined by the Pathology Review Committee of the trial and we compared tumours of patients with and without preoperative radiotherapy. Tumours of patients who were treated with preoperative radiotherapy were smaller, more often mucinous carcinomas (13% versus 7%, p < 0.001) and more often poorly differentiated (35% versus 24%, p<0.001). After radiotherapy, there was less inflammatory reaction around the tumour (extensive in 7% versus 18%, p<0.001), which was mainly caused by a decrease in T lymphocytes and neutrophil granulocytes. The fibroblastic reaction was more pronounced in the radiotherapy group (extensive in 22% versus 10%, p <0.001). Remarkable histological alterations occurred within a week after 5 days of irradiation of rectal carcinomas. The prognostic value of these factors therefore needs to be re-evaluated for irradiated patients.

Entities:  

Mesh:

Year:  2002        PMID: 12081199     DOI: 10.1002/path.1098

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  23 in total

1.  A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation.

Authors:  Runjan Chetty; Pelvender Gill; Dhirendra Govender; Adrian Bateman; Hee Jin Chang; David Driman; Fraser Duthie; Marisa Gomez; Eleanor Jaynes; Cheok Soon Lee; Michael Locketz; Claudia Mescoli; Corwyn Rowsell; Anne Rullier; Stefano Serra; Neil Shepherd; Eva Szentgyorgyi; Rajkumar Vajpeyi; Lai Mun Wang
Journal:  Virchows Arch       Date:  2012-01-13       Impact factor: 4.064

2.  Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Authors:  Jeremy R Jass; Michael J O'Brien; Robert H Riddell; Dale C Snover
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

3.  Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy.

Authors:  Lukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Jacek Starzewski; Zbigniew Lorenc
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma.

Authors:  F Bretagnol; B Lelong; C Laurent; V Moutardier; A Rullier; G Monges; J-R Delpero; E Rullier
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

Review 5.  The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment.

Authors:  Carmen Faus; Desamparados Roda; Matteo Frasson; Susana Roselló; Eduardo García-Granero; Blas Flor-Lorente; Samuel Navarro
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

6.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

Review 7.  Advances in the care of patients with mucinous colorectal cancer.

Authors:  Niek Hugen; Gina Brown; Robert Glynne-Jones; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

8.  Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.

Authors:  Suvi Tuulia Avoranta; Eija Annika Korkeila; Kari Juhani Syrjänen; Seppo Olavi Pyrhönen; Jari Toivo Tapio Sundström
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 9.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

10.  Do Acellular Mucin Pools in Resection Margins for Rectal Cancer Influence Outcomes?

Authors:  Parag Ingle; Munita Bal; Reena Engineer; Vikas Ostwal; Ashwin Desouza; Avanish Saklani
Journal:  Indian J Surg Oncol       Date:  2019-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.